Mary Anne Greenberg

The importance of life sciences companies focused on rare diseases to take early steps to bridge connections with patients, caregivers, and healthcare providers.

Therapeutic companies that work with rare diseases must take early steps to build relationships with patients, caregivers, and HCPs.

With the role of Medical Information in pharma companies changing in recent years, this article outlines some current and future trends including globalization and the use of data to drive change.